Resection of supratentorial brain metastases with intraoperative radiotherapy. Is it safe? Analysis and experiences of a single center cohort.

Publication

Resection of supratentorial brain metastases with intraoperative radiotherapy. Is it safe? Analysis and experiences of a single center cohort.

Journal Paper/Review - Dec 26, 2022

Krauss Philipp, Steininger Kathrin, Motov Stefan, Sommer Bjoern, Bonk Maximilian Niklas, Cortes Abraham, Wolfert Christina, Stueben Georg, Shiban Ehab, Kahl Klaus Henning

Citation

Krauss P, Steininger K, Motov S, Sommer B, Bonk M, Cortes A, Wolfert C, Stueben G, Shiban E, Kahl K. Resection of supratentorial brain metastases with intraoperative radiotherapy. Is it safe? Analysis and experiences of a single center cohort. Front Surg 2022; 9:1071804.

Type

Journal Paper/Review (English)

Journal

Front Surg 2022; 9

Publication Date

Dec 26, 2022

Issn Print

2296-875X

Pages

1071804

Brief description/objective

Intraoperative Radiotherapy (ioRT) is an emerging treatment option in oncologic surgery for various diseases including intraaxial brain lesions to improve surgical outcome and accelerate the adjuvant oncologic therapy. Despite its use in glioma surgery, the application and data regarding ioRT in the treatment of brain metastases (BMs) is sparse. Here were report the largest series of supratentorial BMs treated with resection and ioRT according to functional outcome and adverse events.